Negative signals from FcεRI engagement attenuate mast cell functions

Archivum Immunologiae et Therapiae Experimentalis

Volumn 55, Issue 4, 2007, Pages 219-229

  Molfetta, Rosa ^a   Peruzzi, Giovanna ^a   Santoni, Angela ^a   Paolini, Rossella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Fc RI; Mast cell; Negative regulation; Signal transduction

Indexed keywords

ADAPTOR PROTEIN; HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E; LAT PROTEIN; LIPID PHOSPHATASE; PHOSPHATASE; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; RAB PROTEIN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; PROTEIN SUBUNIT; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ALLERGY; ANTIBODY STRUCTURE; B LYMPHOCYTE; BETA CHAIN; CELL ACTIVATION; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; IMMUNOCOMPETENT CELL; MAST CELL; NONHUMAN; PROTEIN MOTIF; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; CAPPING PHENOMENON; ENZYMOLOGY; FEEDBACK SYSTEM; HYPERSENSITIVITY; METABOLISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; FEEDBACK, BIOCHEMICAL; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MAST CELLS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN SUBUNITS; PROTEIN-TYROSINE KINASES; RECEPTOR AGGREGATION; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 34547878349     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-007-0028-4     Document Type: Review

References (75)

1. Abramson J., Rozenblum G. and Pecht I. (2003): Dok protein family members are involved in signaling mediated by the type 1 Fcepsilon receptor. Eur. J. Immunol., 33, 85-91.
2. Abramson J., Xu R. and Pecht I. (2002): An unusual inhibitory receptor-the mast cell function-associated antigen (MAFA). Mol. Immunol., 38, 1307-1313.
3. Blank U. and Rivera J. (2004): The ins and outs of IgE - dependent mast-cell exocytosis. Trends Immunol., 25, 266-273.
4. Bruhns P., Fremont S. and Daeron M. (2005): Regulation of allergy by Fc receptors. Curr. Opin. Immunol., 17, 662-669.
5. Cantley L. C. and Neel B. G. (1999): New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA, 96, 4240-4245.
6. Costello P. S., Turner M., Walters A. E., Cunningham C. N., Bauer P. H., Downward J. and Tybulewicz V. L. (1996): Critical role for the tyrosine kinase Syk in signaling through the high affinity IgE receptor of mast cells. Oncogene, 13, 2595-2605.
7. Deane J. A. and Fruman D.A. (2004): Phosphoinositide 3 - kinase: diverse roles in immune cell activation. Annu. Rev. Immunol., 22, 563-598.
8. Dikic I. (2002): CIN85/CMS family of adaptor molecules. FEBS Lett., 529, 110-115.
9. Duan L., Reddi A. L., Ghosh A., Dimri M. and Band H. (2004): The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling. Immunity, 21, 7-17.
10. Elsasser S. and Finley D. (2005). Delivery of ubiquitinated substrates to protein-unfolding machines. Nat. Cell Biol., 7, 742-710.
11. Furumoto Y., Brooks S., Olivera A., Takagi Y., Miyagishi M., Taira K., Casellas R., Beaven M. A., Gilfillan A. M. and Rivera J. (2006): Cutting Edge: Lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J. Immunol., 176, 5167-5171.
12. Furumoto Y., Nunomura S., Terada T., Rivera J. and Ra C. (2004): The FcepsilonRIbeta immunoreceptor tyrosine - based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production. J. Biol. Chem., 279, 49177-49187.
13. Galli S. J., Kalesnikoff J., Grimbaldeston M. A., Piliponsky A. M., Williams C. M. and Tsai M. (2005): Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol., 23, 749-786.
14. Gibbs B. F., Rathling A., Zillikens D., Huber M. and Haas H. (2006): Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation. J. Allergy Clin. Immunol., 118, 1060-1067.
15. Gilfillan A. M. and Tkaczyk C. (2006): Integrated pathways for mast-cell activation. Nat. Rev. Immunol., 6, 218-230.
16. Gimborn K., Lessmann E., Kuppig S., Krystal G. and Huber M. (2005): SHIP down-regulates FcepsilonR1 - induced degranulation at supraoptimal IgE or antigen levels. J. Immunol., 174, 507-516.
17. Gomez G., Gonzalez-Espinosa C., Odom S., Baez G., Cid M. E., Ryan J. J. and Rivera J. (2005): Impaired FcepsilonRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J. Immunol., 175, 7602-7610.
18. Gout I., Middleton G., Adu J., Ninkina N. N., Drobot L. B., Filonenko V., Matsuka G., Davies A. M., Waterfield M. and Buchman V. L. (2000): Negative regulation of PI 3 - kinase by Ruk, a novel adaptor protein. EMBO J., 19, 4015-4025.
19. Gustin S. E., Thien C. B. and Langdon W. Y. (2006): Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells. J. Immunol., 177, 5980-5989.
20. Hernandez-Hansen V., Smith A. J., Surviladze Z., Chigaev A., Mazel T., Kalesnikoff J., Lowell C. A., Krystal G., Sklar L. A., Wilson B. S. and Oliver J. M. (2004): Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. J. Immunol., 173, 100-112.
21. Hershko A. and Ciechanover A. (1998): The ubiquitin system. Annu. Rev. Biochem., 67, 425-479.
22. Herzog S. and Jumaa H. (2007): The N terminus of the non-T cell activation linker (NTAL) confers inhibitory effects on pre-B cell differentiation. J. Immunol., 178, 2336-2343.
23. Hicke L. (2001): Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol., 2, 195-201.
24. Huber M., Helgason C. D., Damen J. E., Liu L., Humphries R. K. and Krystal G. (1998): The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. USA, 95, 11330-13335.
25. Kalesnikoff J., Baur N., Leitges M., Hughes M. R., Damen J. E., Huber M. and Krystal G. (2002): SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity. J. Immunol., 168, 4737-4746.
26. Kalesnikoff J., Rios E. J., Chen C. C., Barbieri M. A., Tsai M., Tam S. Y. and Galli S. J. (2007): Roles of RabGEF1/Rabex-5 domains in regulating FcepsilonRI surface expression and FcepsilonRI-dependent responses in mast cells. Blood (in press).
27. Katz H. R. (2002): Inhibitory receptors and allergy. Curr. Opin. Immunol., 14, 698-704.
28. Kawakami Y., Kitaura J., Satterthwaite A. B., Kato R. M., Asai K., Hartman S. E., Maeda-Yamamoto M., Lowell C. A., Rawlings D. J., Witte O. N. and Kawakami T. (2000): Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J. Immunol., 165, 1210-1219.
29. Kimura T., Sakamoto H., Appella E. and Siraganian R. P. (1997): The negative signaling molecule SH2 domain-containing inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated beta subunit of the high affinity IgE receptor. J. Biol.Chem., 272, 13991-13996.
30. Kimura T., Zhang J., Sagawa K., Sakaguchi K., Appella E. and Siraganian R. P. (1997): Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor. J. Immunol., 159, 4426-4434.
31. Kovarova M., Wassif C. A., Odom S., Liao K., Porter F. D. and Rivera J. (2006): Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness. J. Exp. Med., 203, 1161-1171.
32. Kyo S., Sada K., Qu X., Maeno K., Miah S. M., Kawauchi-Kamata K. and Yamamura H. (2003): Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon RI-mediated mast cell activation. Genes Cells, 8, 825-836.
33. Lafont F. and Simons K. (2001): Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling. Proc. Natl. Acad. Sci. USA, 98, 3180-3184.
34. Laney J. D. and Hochstrasser M. (1999): Substrate targeting in the ubiquitin system. Cell, 97, 427-430.
35. Lin S., Cicala C., Scharenberg A. M. and Kinet J.-P. (1996): The Fc(epsilon)RIbeta subunit functions as an amplifier of Fc(epsilon)RIgamma- mediated cell activation signals. Cell, 85, 985-995.
36. Magro A. M. and Alexander A. (1974): Histamine release: in vitro studies of the inhibitory region of the dose - response curve. J. Immunol., 112, 1762-1765.
37. Malbec O., Malissen M., Isnardi I., Lesourne R., Mura A. M., Fridman W. H., Malissen B. and Daeron M. (2004): Linker for activation of T cells integrates positive and negative signaling in mast cells. J. Immunol., 173, 5086-5094.
38. Marshall J. S. (2004): Mast-cell responses to pathogens. Nat. Rev. Immunol., 4, 787-799.
39. Metzger H. (1992): The receptor with high affinity for IgE. Immunol. Rev., 125, 37-48.
40. Molfetta R., Belleudi F., Peruzzi G., Morrone S., Leone L., Dikic I., Piccoli M., Frati L., Torrisi M. R., Santoni A. and Paolini R. (2005): CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechanism to dampen mast cell function. J. Immunol., 175, 4208-4216.
41. Monteiro R. C., Hostoffer R. W., Cooper M. D., Bonner J. R., Gartland G. L. and Kubagawa H. (1993): Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J. Clin. Invest., 92, 1681-1685.
42. Mukhopadhyay D. and Riezman H. (2007): Proteasome-independent functions of ubiquitn in endocytosis and signaling. Science, 315, 201-205.
43. Nadler M. J., Matthews S. A., Turner H. and Kinet J.-P. (2000): Signal transduction by the high-affinity immunoglobulin E receptor Fcepsilon RI: coupling form to function. Adv. Immunol., 76, 325-355.
44. Odom S., Gomez G., Kovarova M., Furumoto Y., Ryan J. J., Wright H. V., Gonzalez-Espinosa C., Hibbs M. L., Harder K. W. and Rivera J. (2004): Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med., 199, 1491-1502.
45. Oh S. Y., Zheng T., Bailey M. L., Barber D. L., Schroeder J. T., Kim Y. K. and Zhu Z. (2007): Src homology 2 domain-containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung. J. Allergy Clin. Immunol., 119, 123-131.
46. Ortega E., Schweitzer-Stenner R. and Pecht I. (1988): Possible orientational constraints determine secretory signals induced by aggregation of IgE receptors on mast cells. EMBO J., 7, 4101-4109.
47. Ota Y., Beitz L. O., Scharenberg A. M., Donovan J. A., Kinet J.-P. and Samelson L. E. (1996): Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells. J. Exp. Med., 184, 1713-1723.
48. Ota Y. and Samelson L E. (1997): The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. Science, 276, 418-420.
49. Paolini R. and Kinet J.-P. (1993): Cell surface control of the multiubiquitination and deubiquitination of high-affinity immunoglobulin E receptors. EMBO J., 12, 779-786.
50. Paolini R., Molfetta R., Beitz L. O., Zhang J., Scharenberg A. M., Piccoli M., Frati L., Siraganian R. and Santoni A. (2002): Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of Fcepsilon RI and Syk in RBL cells. J. Biol. Chem., 277, 36940-36947.
51. Parravicini V., Gadina M., Kovarova M., Odom S., Gonzalez-Espinosa C., Furumoto Y., Saitoh S., Samelson L. E., O'Shea J. J. and Rivera J. (2002): Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol., 3, 741-748.
52. Pasquier B., Launay P., Kanamaru Y., Moura I.C., Pfirsch S., Ruffie C., Henin D., Benhamou M., Pretolani M., Blank U. and Monteiro R. C. (2005): Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity, 22, 31-42.
53. Petrelli A., Gilestro G. F., Lanzardo S., Comoglio P. M., Migone N. and Giordano S. (2002): The endophilin - CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature, 416, 187-190.
54. Qu X., Sada K., Kyo S., Maeno K., Miah S. M. and Yamamura H. (2004): Negative regulation of FcepsilonRI - mediated mast cell activation by a ubiquitin-protein ligase Cbl-b. Blood, 103, 1779-1786.
55. Rivera J. and Gilfillan A. M. (2006): Molecular regulation of mast cell activation. J. Allergy Clin. Immunol., 117, 1214-1225.
56. Robertson D., Holowka D. and Baird B. (1986): Cross-linking of immunoglobulin E-receptor complexes induces their interaction with the cytoskeleton of rat basophilic leukemia cells. J. Immunol., 136, 4565-4572.
57. Ryan P. E., Davies G. C., Nau M. M. and Lipkowitz S. (2006): Regulating the regulator: negative regulation of Cbl ubiquitin ligases. Trends Biochem. Sci., 31, 79-88.
58. Saitoh S., Odom S., Gomez G., Sommers C. L., Young H. A., Rivera J. and Samelson L. E. (2003): The four distal tyrosines are required for LAT-dependent signaling in FcepsilonRI-mediated mast cell activation. J. Exp. Med., 198, 831-843.
59. Schmidt M. H., Dikic I. and Bogler O. (2005): Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities. J. Biol. Chem., 280, 3414-3425.
60. Siraganian R. P. (2003): Mast cell signal transduction from the high-affinity IgE receptor. Curr. Opin. Immunol., 15, 639-646.
61. Soubeyran P., Kowanetz K., Szymkiewicz I., Langdon W. Y. and Dikic I. (2002): Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature, 416, 183-187.
62. Szymkiewicz I., Kowanetz K., Soubeyran P., Dinarina A., Lipkowitz S. and Dikic I. (2002): CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. J. Biol. Chem., 277, 39666-39672.
63. Tam S. Y., Tsai M., Snouwaert J. N., Kalesnikoff J Scherrer D., Nakae S., Chatterjea D., Bouley D. M. and Galli S. J. (2004): RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Nat. Immunol., 5, 844-852.
64. Thien C. B. and Langdon W. Y. (2005): c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signaling responses. Biochem. J., 391, 153-166.
65. Thrower J. S., Hoffman L., Rechsteiner M. and Pickart C. M. (2000): Recognition of the polyubiquitin proteolytic signal. EMBO J., 19, 94-102.
66. Tkaczyk C., Horejsi V., Iwaki S., Draber P., Samelson L. E., Satterthwaite A. B., Nahm D. H., Metcalfe D. D. and Gilfillan A. M. (2004): NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and FcepsilonRI aggregation. Blood, 104, 207-214.
67. Torigoe C., Inman J. K. and Metzger H. (1998): An unusual mechanism for ligand antagonism. Science, 281, 568-572.
68. Volna P., Lebduska P., Draberova L., Simova S., Heneberg P., Boubelik M., Bugajev V., Malissen B., Wilson B. S., Horejsi V., Malissen M. and Draber P. (2004): Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL. J. Exp. Med., 200, 1001-1013.
69. Vonakis B. M., Gibbons S. Jr., Sora R., Langdon J. M. and MacDonald S. M. (2001): Src homology 2 domain-containing inositol 5′ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J. Allergy Clin. Immunol., 108, 822-831.
70. Weissman A. M. (2001): Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell. Biol., 2, 169-178.
71. Xiao W., Nishimoto H., Hong H., Kitaura J., Nunomura S., Maeda-Yamamoto M., Kawakami Y., Lowell C. A., Ra C. and Kawakami T. (2005): Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. J. Immunol., 175, 6885-6892.
72. Zhang J., Chiang Y. J., Hodes R. J. and Siraganian R. P. (2004): Inactivation of c-Cbl or Cbl-b differentially affects signaling from the high affinity IgE receptor. J. Immunol., 173, 1811-1818.
73. Zhu M., Janssen E., Leung K. and Zhang W. (2002): Molecular cloning of a novel gene encoding a membrane - associated adaptor protein (LAX) in lymphocyte signaling. J. Biol. Chem., 277, 46151-46158.
74. Zhu M., Liu Y., Koonpaew S., Granillo O. and Zhang W. (2004): Positive and negative regulation of FcepsilonRI - mediated signaling by the adaptor protein LAB/NTAL. J. Exp. Med., 200, 991-1000.
75. Zhu M., Rhee I., Liu Y. and Zhang W. (2006): Negative regulation of Fc epsilonRI-mediated signaling and mast cell function by the adaptor protein LAX. J. Biol. Chem., 281, 18408-18413.